{"id":538801,"date":"2021-09-15T16:08:10","date_gmt":"2021-09-15T20:08:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/"},"modified":"2021-09-15T16:08:10","modified_gmt":"2021-09-15T20:08:10","slug":"neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/","title":{"rendered":"NeuBase\u00a0to Present at the\u00a0Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit\u00a0"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">PITTSBURGH, Sept.  15, 2021  (GLOBE NEWSWIRE) &#8212; NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (\u201cNeuBase\u201d or the \u201cCompany\u201d), a biotechnology platform company Drugging the Genome\u2122 to address disease at the base level using a new class of precision genetic medicines, announced today that Dietrich A. Stephan, Ph.D., Chief Executive Officer of NeuBase, will present a corporate overview at the virtual Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit being held September 20 \u2013 23.<\/p>\n<p align=\"left\">\n        <strong>Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit\u00a0<\/strong><br \/>\n        \n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:15%;width:15%;min-width:15%\">Date:<\/td>\n<td style=\"max-width:85%;width:85%;min-width:85%\">Tuesday,\u00a0September\u00a021st<\/td>\n<\/tr>\n<tr>\n<td>Time:<\/td>\n<td>3:45 p.m. ET<\/td>\n<\/tr>\n<tr>\n<td>Location:<\/td>\n<td>\n            <a href=\"https:\/\/wsw.com\/webcast\/oppenheimer16\/register.aspx?conf=oppenheimer16&amp;page=nbse&amp;url=https:\/\/wsw.com\/webcast\/oppenheimer16\/nbse\/2765336\" rel=\"nofollow noopener\" target=\"_blank\">Webcast Link<\/a> &#8211; or at the company\u2019s website (<a href=\"https:\/\/ir.neubasetherapeutics.com\/news-events\/ir-calendar\" rel=\"nofollow noopener\" target=\"_blank\">click here<\/a>)<\/td>\n<\/tr>\n<\/table>\n<p>\n        <strong>About NeuBase Therapeutics<\/strong><br \/>\n        <br \/>NeuBase is accelerating the genetic revolution by developing a new class of precision genetic medicines which can be designed to increase, decrease, or change gene function, as appropriate, to resolve genetic defects that drive disease. NeuBase\u2019s targeted PATrOL\u2122 therapies are centered around its proprietary drug scaffold to address genetic diseases at the DNA or RNA level by combining the highly targeted approach of traditional genetic therapies with the broad organ distribution capabilities of small molecules. With an initial focus on silencing disease-causing mutations in debilitating neuromuscular, neurological and oncologic disorders, NeuBase is committed to redefining medicine for the millions of patients with both common and rare conditions. To learn more, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-O8Uazh3yb8PNIdAd8xzA6JK1TiIMJN2Ei7Mb5mgeGBU4Fx6JNjbCiqDpBoJ2b1vDIEpQyYKr3A8LxzRNnF4mx5FOddUBDAdLV8OisiBLQIccX530bQIVYp-t0VGeqej\" rel=\"nofollow noopener\" target=\"_blank\">www.neubasetherapeutics.com<\/a>.<\/p>\n<p>\n        <strong>NeuBase Investor Contact:<\/strong>\u00a0<br \/>Daniel Ferry\u00a0<br \/>LifeSci Advisors, LLC<br \/>+1 (617) 430-7576\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=x8nFddtkcF8mRlX9NeiaY6DkzPdQKFH1NFQs7kaaOHUbURfMxWYb3lMxgAa6YMFm-TuCM4gaTMrIABdfx_XcK0hIBMwZw20AChfg7QpF99KrUjrDcM58n60-ysX0RYfG\" rel=\"nofollow noopener\" target=\"_blank\">daniel@lifesciadvisors.com<\/a><\/p>\n<p>\n        <strong>NeuBase Media Contact:<\/strong><br \/>\n        <br \/>Jessica Yingling, Ph.D.<br \/>Little Dog Communications Inc.<br \/>+1 (858) 344-8091<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=L-YFCMUdyj7nInOIfHQItfezDluKViAV3Y5ZQCliBXM3JnLZ0zGsym-Hu2DgBTDK93SUI1b78ZDXzgrbsWhbIIxw7H0arI8Ebsp0mI9r9nQ=\" rel=\"nofollow noopener\" target=\"_blank\">jessica@litldog.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNjAzNyM0NDA1NTkzIzUwMDA2NDg3Ng==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OTliODc5YzYtMTczMy00YTFlLWE1ODgtNmQ5Zjg5Njk5ZDkzLTUwMDA2NDg3Ng==\/tiny\/NeuBase-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PITTSBURGH, Sept. 15, 2021 (GLOBE NEWSWIRE) &#8212; NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (\u201cNeuBase\u201d or the \u201cCompany\u201d), a biotechnology platform company Drugging the Genome\u2122 to address disease at the base level using a new class of precision genetic medicines, announced today that Dietrich A. Stephan, Ph.D., Chief Executive Officer of NeuBase, will present a corporate overview at the virtual Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit being held September 20 \u2013 23. Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit\u00a0 Date: Tuesday,\u00a0September\u00a021st Time: 3:45 p.m. ET Location: Webcast Link &#8211; or at the company\u2019s website (click here) About NeuBase Therapeutics NeuBase is accelerating the genetic revolution by developing a new class of precision genetic medicines which can be designed to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NeuBase\u00a0to Present at the\u00a0Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit\u00a0&#8220;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-538801","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NeuBase\u00a0to Present at the\u00a0Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit\u00a0 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NeuBase\u00a0to Present at the\u00a0Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit\u00a0 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PITTSBURGH, Sept. 15, 2021 (GLOBE NEWSWIRE) &#8212; NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (\u201cNeuBase\u201d or the \u201cCompany\u201d), a biotechnology platform company Drugging the Genome\u2122 to address disease at the base level using a new class of precision genetic medicines, announced today that Dietrich A. Stephan, Ph.D., Chief Executive Officer of NeuBase, will present a corporate overview at the virtual Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit being held September 20 \u2013 23. Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit\u00a0 Date: Tuesday,\u00a0September\u00a021st Time: 3:45 p.m. ET Location: Webcast Link &#8211; or at the company\u2019s website (click here) About NeuBase Therapeutics NeuBase is accelerating the genetic revolution by developing a new class of precision genetic medicines which can be designed to &hellip; Continue reading &quot;NeuBase\u00a0to Present at the\u00a0Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit\u00a0&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-15T20:08:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNjAzNyM0NDA1NTkzIzUwMDA2NDg3Ng==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NeuBase\u00a0to Present at the\u00a0Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit\u00a0\",\"datePublished\":\"2021-09-15T20:08:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\\\/\"},\"wordCount\":254,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNjAzNyM0NDA1NTkzIzUwMDA2NDg3Ng==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\\\/\",\"name\":\"NeuBase\u00a0to Present at the\u00a0Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit\u00a0 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNjAzNyM0NDA1NTkzIzUwMDA2NDg3Ng==\",\"datePublished\":\"2021-09-15T20:08:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNjAzNyM0NDA1NTkzIzUwMDA2NDg3Ng==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNjAzNyM0NDA1NTkzIzUwMDA2NDg3Ng==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NeuBase\u00a0to Present at the\u00a0Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NeuBase\u00a0to Present at the\u00a0Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit\u00a0 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/","og_locale":"en_US","og_type":"article","og_title":"NeuBase\u00a0to Present at the\u00a0Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit\u00a0 - Market Newsdesk","og_description":"PITTSBURGH, Sept. 15, 2021 (GLOBE NEWSWIRE) &#8212; NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (\u201cNeuBase\u201d or the \u201cCompany\u201d), a biotechnology platform company Drugging the Genome\u2122 to address disease at the base level using a new class of precision genetic medicines, announced today that Dietrich A. Stephan, Ph.D., Chief Executive Officer of NeuBase, will present a corporate overview at the virtual Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit being held September 20 \u2013 23. Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit\u00a0 Date: Tuesday,\u00a0September\u00a021st Time: 3:45 p.m. ET Location: Webcast Link &#8211; or at the company\u2019s website (click here) About NeuBase Therapeutics NeuBase is accelerating the genetic revolution by developing a new class of precision genetic medicines which can be designed to &hellip; Continue reading \"NeuBase\u00a0to Present at the\u00a0Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit\u00a0\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-15T20:08:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNjAzNyM0NDA1NTkzIzUwMDA2NDg3Ng==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NeuBase\u00a0to Present at the\u00a0Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit\u00a0","datePublished":"2021-09-15T20:08:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/"},"wordCount":254,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNjAzNyM0NDA1NTkzIzUwMDA2NDg3Ng==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/","name":"NeuBase\u00a0to Present at the\u00a0Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit\u00a0 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNjAzNyM0NDA1NTkzIzUwMDA2NDg3Ng==","datePublished":"2021-09-15T20:08:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNjAzNyM0NDA1NTkzIzUwMDA2NDg3Ng==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNjAzNyM0NDA1NTkzIzUwMDA2NDg3Ng=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neubase-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NeuBase\u00a0to Present at the\u00a0Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/538801","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=538801"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/538801\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=538801"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=538801"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=538801"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}